CERo Therapeutics Holdings (CERO) Financial Statements
CERo Therapeutics Holdings Financial Overview
CERo Therapeutics Holdings's market cap is currently $318.84K. The company's EPS TTM is $-12.30; its P/E ratio is 0.00; CERo Therapeutics Holdings has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -1.09M | $ -1.16M | $ -1.12M | $ 0.00 | $ 0.00 |
| Operating Income | $ -18.46M | $ -15.30M | $ -2.93M | $ -2.91M | $ -332.03K |
| EBITDA | $ -17.38M | $ -6.57M | $ -1.32M | $ -1.83M | $ 403.06K |
| Net Income | $ -19.92M | $ -7.73M | $ -2.54K | $ -667.74K | $ -315.55K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.66M | $ 3.33M | $ 1.60M | $ 42.14M | $ 1.10M |
| Total Assets | $ 3.64M | $ 6.21M | $ 5.13M | $ 42.37M | $ 180.08M |
| Total Debt | $ 699.11K | $ 1.58M | $ 1.55M | $ 650.00K | $ 3.60M |
| Net Debt | $ -963.27K | $ -1.75M | $ 1.46M | $ -41.49M | $ 2.50M |
| Total Liabilities | $ 9.09M | $ 8.10M | $ 47.18M | $ 39.90M | $ 9.25M |
| Stockholders' Equity | $ -5.45M | $ -1.89M | $ -5.76M | $ 2.47M | $ 170.83M |
| Cash Flow | |||||
| Free Cash Flow | $ -16.08M | $ -5.79M | $ -5.79M | $ -1.79M | $ -1.31M |
| Operating Cash Flow | $ -16.08M | $ -5.79M | $ -5.79M | $ -1.09M | $ -697.11K |
| Investing Cash Flow | $ 500.00K | $ 0.00 | $ -7.94K | $ 180.84M | $ -178.50M |
| Financing Cash Flow | $ 13.92M | $ 571.68K | $ 571.68K | $ -138.70M | $ 180.30M |
Currency in USD